Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens

BACKGROUND: Hydroxyurea (HU) is an immunomodulatory agent that has been documented to enhance the antiretroviral activity of nucleoside reverse transcriptase inhibitors, such as abacavir (ABC) and didanosine (ddI), and would be expected to improve virologic efficacy. METHODS: A 48-week, phase IV, mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Swindells, Susan, Cohen, Calvin J, Berger, Daniel S, Tashima, Karen T, Liao, Qiming, Pobiner, Bonnie F, Snidow, Jerry W, Pakes, Gary E, Hernandez, Jaime E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090576/
https://www.ncbi.nlm.nih.gov/pubmed/15819974
http://dx.doi.org/10.1186/1471-2334-5-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090576/
https://www.ncbi.nlm.nih.gov/pubmed/15819974
http://dx.doi.org/10.1186/1471-2334-5-23

Ejemplares similares